Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth F Krakow

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Current Opinion in Hematology|October 8, 2019
Current state of nonengrafting donor leukocyte infusion (focus on microtransplantation for acute myeloid leukemia)Elizabeth F Krakow
The International Journal of Biostatistics|October 27, 2022
"Show me the DAG!"Elizabeth F Krakow
MDM Policy & Practice|April 5, 2019
The Challenges of Informed Consent in High-Stakes, Randomized Oncology Trials: A Systematic ReviewJulia M Nathe, Elizabeth F Krakow
Bone Marrow Transplantation|April 15, 2020
Precision medicine: Statistical methods for estimating adaptive treatment strategiesErica E M Moodie, Elizabeth F Krakow
Frontiers in Immunology|June 1, 2023
Trans-population graph-based coverage optimization of allogeneic cellular therapySapir Israeli, Elizabeth F Krakow, Martin Maiers, et al.
Blood Reviews|September 18, 2014
Harnessing the power of alloreactivity without triggering graft-versus-host disease: how non-engrafting alloreactive cellular therapy might change the landscape of acute myeloid leukemia treatmentElizabeth F Krakow, Julie Bergeron, Silvy Lachance, et al.
Current Drug Targets|March 5, 2015
Do We Need Full Donor Chimerism? How Alloreactive Cell Therapies without Substantial Engraftment Might Treat Hematologic CancersElizabeth F Krakow, Hui-Sheng Ai, Brian Shaffer, et al.
American Journal of Clinical Pathology|June 21, 2007
Influence of sample collection and storage on the detection of platelet factor 4-heparin antibodiesElizabeth F Krakow, Ranjit Goudar, Elizabeth Petzold, et al.
Biometrical Journal. Biometrische Zeitschrift|May 17, 2018
A cure-rate model for Q-learning: Estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patientsErica E M Moodie, David A Stephens, Shomoita Alam, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2018
Quality of Life of Caregivers of Hematopoietic Cell Transplant RecipientsKareem Jamani, Lynn E Onstad, Merav Bar, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Current Opinion in Hematology|October 8, 2019
Current state of nonengrafting donor leukocyte infusion (focus on microtransplantation for acute myeloid leukemia)Elizabeth F Krakow
The International Journal of Biostatistics|October 27, 2022
"Show me the DAG!"Elizabeth F Krakow
MDM Policy & Practice|April 5, 2019
The Challenges of Informed Consent in High-Stakes, Randomized Oncology Trials: A Systematic ReviewJulia M Nathe, Elizabeth F Krakow
Bone Marrow Transplantation|April 15, 2020
Precision medicine: Statistical methods for estimating adaptive treatment strategiesErica E M Moodie, Elizabeth F Krakow
Frontiers in Immunology|June 1, 2023
Trans-population graph-based coverage optimization of allogeneic cellular therapySapir Israeli, Elizabeth F Krakow, Martin Maiers, et al.
Blood Reviews|September 18, 2014
Harnessing the power of alloreactivity without triggering graft-versus-host disease: how non-engrafting alloreactive cellular therapy might change the landscape of acute myeloid leukemia treatmentElizabeth F Krakow, Julie Bergeron, Silvy Lachance, et al.
Current Drug Targets|March 5, 2015
Do We Need Full Donor Chimerism? How Alloreactive Cell Therapies without Substantial Engraftment Might Treat Hematologic CancersElizabeth F Krakow, Hui-Sheng Ai, Brian Shaffer, et al.
American Journal of Clinical Pathology|June 21, 2007
Influence of sample collection and storage on the detection of platelet factor 4-heparin antibodiesElizabeth F Krakow, Ranjit Goudar, Elizabeth Petzold, et al.
Biometrical Journal. Biometrische Zeitschrift|May 17, 2018
A cure-rate model for Q-learning: Estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patientsErica E M Moodie, David A Stephens, Shomoita Alam, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2018
Quality of Life of Caregivers of Hematopoietic Cell Transplant RecipientsKareem Jamani, Lynn E Onstad, Merav Bar, et al.
Pageof 3